FDA Approved: CARBAGLU — Supplemental Application (Recordati Rare Diseases)

View source ↗

Summary

FDA approved a supplemental application for CARBAGLU (carbaglumic acid) submitted by Recordati Rare Diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperammonemia
• N-acetylglutamate Synthase Deficiency
• Urea Cycle Disorder

Drugs mentioned

• Carbaglu (carglumic acid)

Snippet

SUPPL AP for CARBAGLU (CARGLUMIC ACID)